As per the research conducted by Future Market Insights, during the forecast period, the global blood bags market is set to gain a valuation of USD 439.2 million in 2023 and is going to further expand at a CAGR of 6.7% to reach the valuation of USD 840.1 million by the year 2033. The sales of blood bags are anticipated to bolster with the top 3 countries projected to hold approximately 35%-40% of the market by the end of 2023.
The blood bags with capacity 250 ml - 500 ml is projected to remain the leading segment during the forecast period. The target segment is projected to grow 1.6 times the current market value during 2023 to 2033.
| Attributes | Details |
|---|---|
| Market Size 2023 | USD 439.2 million |
| Market Size 2033 | USD 840.1 million |
| Value CAGR (2023 to 2033) | 6.7% |
| Collective Value Share: Top 5 Companies (2022A) | 15%-20% |
With the surge in demand for secure packaging to transport blood propel the demand for blood bags. The global blood bags market is estimated to reach USD 840.1 million by 2033, increasing at a CAGR of 6.7% throughout the forecast period.
The blood bags market is expected to experience a lucrative growth outlook during the forecast period. A new estimation predicts that blood bags sales will rise during 2023 to 2033 and is projected to generate an attractive incremental growth opportunity of USD 427.7 million.
The increased awareness about blood donation result in increased number of blood donors, which is gradually resulting in the growth of the blood bags market. The blood bags market is predicted to expand 2.0 times the current market value during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global blood bags market registered a CAGR of 6.4% during the historic period with a market value of USD 412.4 million in 2022. This growth can be attributed to several factors, including the increasing demand for blood and blood products, the rise in the number of blood donations, and the growing prevalence of chronic diseases such as cancer and haemophilia.
Blood components like red blood cells (RBCs), white blood cells (WBCs), and blood platelets are transported and stored in blood bags. The blood bags must be used to store both the blood and its constituent parts. The blood is extremely sensitive to changes in temperature, light, and air, blood bags are required to retain blood and its constituent parts.
For the collection, storage, and transportation of blood and its constituent parts, blood bags have taken the position of glass bottles. The blood bags are designed in a way that makes it simple to separate the various components of the blood that has been collected. Accidents are happening more frequently, which is driving up demand for blood bags.
In addition, technological advancements in the manufacturing of blood bags, such as the use of PVC-free materials and improved sterilization techniques, are also contributing to the blood bags market growth.
The market is also facing challenges such as the high cost of blood bags and stringent regulations for their manufacturing and distribution. The COVID-19 pandemic had a moderate impact on the market, with disruptions in the supply chain and reduced blood donations in some regions. Overall, the blood bags market is expected to continue to grow, driven by increasing demand and advancements in technology.
The rising awareness about blood donation is a significant driver for the growth of the blood bags market. As more people become aware of the importance of blood donation, there is an increase in the number of blood donations.
This leads to a higher demand for blood bags. Blood bags are essential for the collection, storage, and transportation of blood and blood components. With more people donating blood, there is a need for an adequate supply of blood bags to ensure that the collected blood is safe and can be used for transfusion when needed.
Moreover, the increasing awareness of the need for safe and high-quality blood transport is driving the demand for blood bags that are manufactured to high standards and quality. This, in turn, is leading to the adoption of advanced blood bag technologies that improve the safety, reliability, and durability of blood bags.
Principal Consultant
Blood bags are used in a wide range of healthcare applications, including blood transfusions, blood component therapy, and blood collection for testing and analysis. As the healthcare sector expands, the demand for these applications also increases, driving the need for more blood bags.
In addition, the growth of the healthcare sector is also leading to advancements in blood bag technologies, such as the use of PVC-free materials and improved sterilization techniques. These advancements are improving the safety and quality of blood bags, leading to better patient outcomes and driving the demand for more advanced blood bag technologies.
Overall, the growing healthcare sector is a significant driver for the blood bags market, as it increases the demand for blood bags and supports the adoption of advanced blood bag technologies.
The triple blood bags is expected to experience the consistent demand in the market during the forecast period. The same segment is projected to grow 1.7 times the current market value during the forecast period.
These bags are used for collection, preservation, and transfusion of Packed Red Blood Cells (PRBC) Platelets (PLT) and Plasma (FFP). The surge in need for separating blood into three components fuel the demand for triple blood bags.
The leading end user in the blood bags market is the hospitals segment followed by blood banks segment. Hospitals and blood banks are the primary facilities where blood bags are used for blood collection, storage, and transfusion.
Hospitals use blood bags for a wide range of medical procedures, including surgeries, trauma cases, and critical care treatments, where blood transfusions may be necessary. Blood banks collect and store blood and blood components for use in emergencies and medical treatments.
The growing demand for blood bags in hospitals and blood banks is driven by the increasing prevalence of chronic diseases, growing aging population, rising number of surgeries, and trauma cases.
The COVID-19 pandemic has also increased the demand for blood bags in hospitals as many patients required blood transfusions during their treatment. Both the segment collectively are estimated to hold nearly 61% of the market value share by the end of 2023.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Countries | USA |
|---|---|
| Market Share (2023) | 28.3% |
| Market Share (2033) | 25.7% |
| BPS Analysis | -300 |
| Countries | China |
|---|---|
| Market Share (2023) | 9.2% |
| Market Share (2033) | 11.0% |
| BPS Analysis | +220 |
| Countries | Germany |
|---|---|
| Market Share (2023) | 6.7% |
| Market Share (2033) | 5.2% |
| BPS Analysis | -100 |
| Countries | UNITED KINGDOM |
|---|---|
| Market Share (2023) | 5.3% |
| Market Share (2033) | 5.7% |
| BPS Analysis | +30 |
| Countries | Canada |
|---|---|
| Market Share (2023) | 4.4% |
| Market Share (2033) | 6.1% |
| BPS Analysis | +140 |
The USA is projected to hold around 84% of the market value share by the end of 2025. The USA has advanced medical infrastructure, technological innovations in blood collection and storage, strong regulatory standards. Also, the presence of major pharmaceutical companies that invest heavily in the development of blood-related products.
The USA has a large population and a robust healthcare system that demands a high volume of blood and blood-related products. According to the American National Red Cross, in February 2021, approximately 29,000 units of red blood cells were required daily and that nearly 21 million blood components were transfused in the USA This factor fuel the demand for blood bags.
India's road traffic accidents have been surging in recent years, leading to an increase in demand for blood in the country. This is because many of the accident victims require blood transfusions as a part of their treatment, and the demand for blood bags increases accordingly.
According to Government of India ministry of road transport and highways transport, during the year 2021, a total number of 4,12,432 road accidents have been reported in the country, claiming 1,53,972 lives and causing injuries to 3,84,448 persons.
People suffer non-fatal injuries, and many of them develop disabilities as a result. As a result, the growth of the blood bags market is closely tied to the incidence of road traffic accidents in India. India blood bags market is anticipated to register a CAGR of XX% during 2023 to 2033.
The major players in the market are gaining market value by developing new innovations and advancement in the blood bags market. Recent activities and mergers implemented by the leading player in the market are:
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.7% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million, Volume in Units and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Capacity, End User, Region |
| Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan Countries; Baltic Countries; Middle East & Africa |
| Key Countries Covered | USA, Canada, Mexico, Brazil, Germany, UNITED KINGDOM, France, Italy, Spain, Russia, China, Japan, India, GCC countries, Australia & New Zealand |
| Key Companies Profiled | Haemonetics Corporation; Terumo Blood and Cell Technologies; Macopharma USA; Fresnuise Kabi India Pvt., Ltd; Qingdao Sinoland International Trade Co.; Genesis BPS, BL Lifesciences; Mitra Industries Pvt. Ltd.; Suru International Pvt. Ltd.; B. Braun Melsungen AG (Germany); HLL Lifecare Limited; Wego Group; Polymedicure Limited; Kawasumi Laboratories Inc.; GVS S.p.A.; VOGT Medical Ltd.; Advin Health Care; QED Kares Pvt. Ltd.; Terumo Pepnol Pvt. Ltd.; JMS North America Corporation; AdvaCare Pharma; Ishwari Health Care Pvt. Ltd.; Imperial Biotech Pvt. Ltd.; Lmb Technologies GmbH; Vardha Health Care; PVC Med Alliance; Marg Pharma Ltd.; Narang Medical Limited; Suru International Pvt. Ltd.; BMS Group; Kansuk ilaç |
| Customization & Pricing | Available upon Request |
In 2022, the market size of the global blood bags market was USD 412.4 million.
The global blood bags market is anticipated to reach USD 439.2 million in 2023.
The global blood bags market valuation is expected to reach USD 840.1 million in 2033.
The projected CAGR for the global blood bags market from 2023 to 2033 is 6.7%.
By product segment, the triple blood bags segment of the global blood bags market is expected to garner a significant value share by 2023.
The hospitals segment of the global blood bags market is predicted to expand rapidly between 2023 and 2033.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product Type 6.2. Capacity 6.3. End User 7. Global Market Analysis and Forecast, By Product Type 7.1. Single Blood Bag 7.2. Double Blood Bag 7.3. Triple Blood Bag 7.4. Quadruple Blood Bag 7.5. Penta Blood Bag 8. Global Market Analysis and Forecast, By Capacity 8.1. Less than 250 ml 8.2. 250 ml - 500 ml 8.3. Above 500 ml 9. Global Market Analysis and Forecast, By End User 9.1. Hospitals 9.2. Diagnostic Centres 9.3. Clinical Research 9.4. Blood Banks 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. East Asia 10.4. South Asia & Pacific 10.5. Western Europe 10.6. Eastern Europe 10.7. Central Asia 10.8. Russia & Belarus 10.9. Balkan Countries 10.10. Baltic Countries 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. East Asia Sales Analysis and Forecast, by Key Segments and Countries 14. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 16. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 17. Central Asia Sales Analysis and Forecast, by Key Segments and Countries 18. Russia & Belarus Sales Analysis and Forecast, by Key Segments and Countries 19. Balkan Countries Sales Analysis and Forecast, by Key Segments and Countries 20. Baltic Countries Sales Analysis and Forecast, by Key Segments and Countries 21. Sales Forecast by Product Type, Capacity, and End User for 30 Countries 22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 23. Company Profile 23.1. Haemonetics Corporation 23.2. Terumo Blood and Cell Technologies 23.3. Macopharma USA 23.4. Fresenius Kabi India Pvt., Ltd 23.5. Qingdao Sinoland International Trade Co. 23.6. Genesis BPS, BL Lifesciences 23.7. Mitra Industries Pvt. Ltd. 23.8. Suru International Pvt. Ltd. 23.9. B. Braun Melsungen AG (Germany) 23.10. HLL Lifecare Limited 23.11. Wego Group 23.12. Polymedicure Limited 23.13. Kawasumi Laboratories Inc. 23.14. GVS S.p.A. 23.15. VOGT Medical Ltd. 23.16. Advin Health Care 23.17. QED Kares Pvt. Ltd. 23.18. Terumo Pepnol Pvt. Ltd. 23.19. JMS North America Corporation 23.20. AdvaCare Pharma
Explore Packaging Insights
View Reports
Blood Bags Market
